Clinical trial
Alpha Omega Trial: Study of Omega-3 Fatty Acids and Coronary Mortality
NCT00127452 · Wageningen University, Other · Completed
Key facts
| NCT number | NCT00127452 |
|---|---|
| Title | Alpha Omega Trial: Study of Omega-3 Fatty Acids and Coronary Mortality |
| Official title | Alpha Omega Trial: A Randomised, Placebo Controlled, Double Blind Intervention Study of the Effect of Low Doses of Omega-3 Fatty Acids on Cardiovascular Diseases in Patients With a History of Myocardial Infarction |
| Lead sponsor | Wageningen University, Other |
| Collaborators | Netherlands Heart Foundation National Heart, Lung, and Blood Institute (NHLBI) NIH Unilever R&D Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Cardiovascular Diseases |
| Intervention type | Dietary Supplement |
| Interventions | margarine spread |
| Enrollment | 4,837 |
| Start date | Apr 1, 2002 |
| Primary completion | Nov 1, 2009 |
| Completion | Jun 1, 2010 |
| First posted | Aug 5, 2005 |
| Last update posted | Jul 7, 2010 |
| Countries | Netherlands |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: